Putative beta-defensin 108A

Also known as: Defensin, beta 108A, Defensin, beta 108C, Putative beta-defensin 108B pseudogene 1/2, DEFB108A, DEFB108C, A8MXU0

Putative beta-defensin 108A (DEFB108A) is a member of the beta-defensin family of antimicrobial peptides, which are characterized by a conserved six-cysteine motif forming three disulfide bridges. Based on sequence homology, its proposed mechanism of action involves disruption of microbial cell membranes through electrostatic interactions with negatively charged bacterial phospholipids, leading to membrane permeabilization and cell death. However, no direct experimental validation of this activity has been published for DEFB108A specifically. Current research status remains strictly experimental, with no peer-reviewed studies indexed in PubMed as of the latest search. The gene is classified as a putative defensin, and its expression, regulation, and functional significance in vivo are uncharacterized. Some databases list DEFB108A as a potential pseudogene or non-functional variant, raising questions about whether it encodes a mature, active peptide. Given the absence of published data, clinical relevance cannot be established. No therapeutic applications, biomarker roles, or disease associations have been investigated. The peptide remains a theoretical entity within genomic annotations, requiring further molecular and functional studies to confirm its existence and activity. For research purposes only — not medical advice.

Key data

Mechanism of action

Has antibacterial activity

Frequently asked questions

Related peptides